Influence of Rosiglitazone on the Ventricular Haemodynamics,Histological Change,and Apoptosis Level of Cardiomyocytes in Rat's Myocardial Infarction Models

Guozheng LAI,Xin TU,Ting LEI,Shixi XIONG,Jianghua REN,Jing WAN
2009-01-01
Abstract:Objective: To observe the effect of Rosiglitazone maleate on the ventricular haemodynamics, histological change, apoptosis level of cardiomyocytes, and peroxisome proliferator-activated receptorγ (PPARγ) gene expression after myocardial infarction in aged rats. Methods: Acute myocardial infarction (AMI) model of aged rat was established by ligation of the left coronary artery. AMI rats were divided into AMIA group (AMI rats without any treatment) and AMIB group (AMI rats were treated with PPARγ agonists Rosiglitazone 5 mg/kg per day). The rats in sham group underwent the same procedures except ligation of the LAD artery. The infarct size and the changes of the cardiac structure after infarction were assessed by the method of hematoxylin-eosin stain. The cardiac function was evaluated by the physiological signal recording system. The apoptosis level was examined with the method of flow cytometry. The expression of PPARγ was examined by RT-PCR. Results: (1)The cardiac function decreased after AMI. Compared with those in the sham group, the mean artery pressure (MAP), left ventricular peak end-systolic pressure (LVPSP) and dp/dtmax AMIA group were decreased respectively (all P<0.05), but left ventricular end-diastolic pressure (LVEDP) increased significantly (P<0.05). (2) After 14 days of treatment by Rosiglitazone, the LVEDP declined (P<0.05),and the infarct size decreased 33% compared with that of AMIA group. The change of the cardiac structure after infarction in AMIB group was better than in AMIA group. (3) AMIA rats' apoptosis level was as high as 21. 15-fold of that in the sham group. Compared with that in AMIA group, after 14 days treatment by Rosiglitazone, the apoptosis level was decreased significantly (P<0.05). (4) Compared with AMIA group and the sham group, expression of PPARγ was increased obviously in AMIB group (both P<0.001). Conclusion: Rosiglitazone can decrease the infarct size and apoptosis level of AMI in rats. The effect of Rosiglitazone may be associated with the increase of PPARγ gene expression, which can protect the function of cardiomyocytes and vessles.
What problem does this paper attempt to address?